ReviewFrontiers in cardiovascular medicine2022

Changing paradigm in the treatment of amyloidosis: From disease-modifying drugs to anti-fibril therapy.

C Cristina Quarta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.